Psychiatric and substance use disorders comorbidities in veterans with hepatitis C virus and HIV coinfection

Current Opinion in Psychiatry

Volumn 22, Issue 4, 2009, Pages 401-408

  Fuller, Bret E ^a,d   Loftis, Jennifer M ^a,b   Rodriguez, Veronica L ^a   McQuesten, Matthew J ^a   Hauser, Peter ^a,c  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c JENS Lab   (United States)

^d PORTLAND VA MEDICAL CENTER   (United States)

Author keywords

Coinfection; Hepatitis C virus; HIV

Indexed keywords

ANTIRETROVIRUS AGENT; PEGINTERFERON; PROTEINASE INHIBITOR; RECOMBINANT INTERFERON; RIBAVIRIN;

AGGRESSION; ANTIVIRAL THERAPY; ANXIETY DISORDER; BIPOLAR DISORDER; COGNITION; COGNITIVE DEFECT; COMORBIDITY; DEPRESSION; DRUG EFFICACY; FATIGUE; GASTROINTESTINAL SYMPTOM; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOSTILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MENTAL DISEASE; MENTAL HEALTH; MIXED INFECTION; PATIENT COMPLIANCE; POSTTRAUMATIC STRESS DISORDER; PREVALENCE; REVIEW; RISK FACTOR; SCREENING; SIDE EFFECT; SUBSTANCE ABUSE; TATTOO; TREATMENT DURATION; VETERAN;

ANTIVIRAL AGENTS; COGNITION DISORDERS; COMORBIDITY; CROSS-SECTIONAL STUDIES; HEPATITIS C, CHRONIC; HIV SEROPOSITIVITY; HUMANS; INTERDISCIPLINARY COMMUNICATION; MEDICATION ADHERENCE; NEUROPSYCHOLOGICAL TESTS; PATIENT CARE TEAM; SUBSTANCE-RELATED DISORDERS; VETERANS;

EID: 67651011588     PISSN: 09517367     EISSN: None     Source Type: Journal    
DOI: 10.1097/YCO.0b013e32832cadb9     Document Type: Review

References (46)

1. Bräu N, Bini E, Shahidi A, et al. Prevalence of hepatitis c and coinfection with HIV among United States veterans in the New York metropolitan area. Am J Gastroenterol 2002; 97:2071-2078. (Pubitemid 34906859)
2. Dominitz J, Boyko E, Koepsell T, et al. Elevated prevalence of hepatitis C infection in users of United States veterans medical centers. Hepatology 2005; 41:88-96. (Pubitemid 40066386)
3. Philips B, Mole L, Backus L, et al. Caring for veterans with HIV disease. Washington DC: Department of Veterans Affairs; 2003.
4. Valdiserri R, Rodriguez F, Holodniy M. Frequency of HIV screening in the Veterans Health Administration: implications for early diagnosis of HIV infection. AIDS Educ Prev 2008; 20:258-264. This article calculated the rate of HIV testing throughout the entire VA system for fiscal year 2006 and showed alarmingly that the rate was only 10%.
5. Backus L, Boothroyd B, Deyton LR. HIV, hepatitis C and HIV/hepatitis C co-infection in vulnerable populations. AIDS 2005; 19:513-519. (Pubitemid 41682164)
6. Bini E, Currie S, Shen H, et al. National multicenter study of HIV testing and HIV seropositivity in patients with chronic hepatitis C virus infection. J Clin Gasteroenterol 2006; 40:732-739. (Pubitemid 44350597)
7. Andersson K, Chung R. Hepatitis C virus in the HIV-infected patient. Clin Liver Dis 2006; 10:303-320.
8. Rosenburg S, Goodman L, Osher F. Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness. Am J Public Health 2001; 91:31-37. (Pubitemid 32049263)
9. Rosenberg S, Drake R, Brunette M, et al. Hepatitis C virus and HIV co-infection in people with severe mental illness and substance use disorders. AIDS 2005; 19:S26-S33. (Pubitemid 41682166)
10. Loftis JM, Hauser P. Prevalence of psychiatric and substance use disorder comorbidities in patients with hepatitis C. Directions Psychiatry 2008; 28:211-226. An important review for the psychiatric and substance abuse comorbidities in HCV patients.
11. Zickmund S, Hillis S, Barnett M, et al. Hepatitis C virus-infected patients report communication problems with physicians. Hepatology 2004; 39:999-1007. (Pubitemid 38428939)
12. Lehman C, Cheung R. Depression, anxiety, posttraumatic stress, and alcoholrelated problems among veterans with chronic hepatitis C. Am J Gastroenterol 2002; 97:2640-2646.
13. Fontana R, Hussain K, Schwartz S, et al. Emotional distress in chronic hepatitis C patients not receiving antiviral therapy. J Hepatol 2002; 36: 401-407. (Pubitemid 34194801)
14. Fireman M, Indest DW, Blackwell A, et al. Addressing tri-morbidity (hepatitis C, psychiatric disorders, and substance use): The importance of routine mental health screening as a component of a comanagement model of care. Clin Infect Dis 2005; 40:S286-S291. (Pubitemid 40490213)
15. el-Serag H, Kunik M, Richardson P, et al. Psychiatric disorders among veterans with hepatitis C infection. Gastroenterology 2002; 123:476-482.
16. Hilsabeck R, Perry W, Hassanein T. Neuropsychological Impairment in patients with chronic hepatitis C. Hepatology 2002; 35:440-446. (Pubitemid 34106387)
17. Hilsabeck R, Hassanein T, Carlson M, et al. Cognitive functioning and psychiatric symptomatology in patients with chronic hepatitis C. J Int Neuropsychol Soc 2003; 9:847-854. (Pubitemid 37139014)
18. White D, Heaton R, Monsch A. Neuropsychological studies of asymptomatic human immunodeficiency virus-type I infected individuals. The HNRC Group. HIV neurobehavioral research center. J Int Neuropsychol Soc 1995; 1:304-315.
19. Huckans M, Seelye A, Parcel T, et al. The cognitive effects of hepatitis C in the presence and absence of a history of substance use disorder. J Int Neuropsychol Soc 2008; 15:69-82. This article is the first to actively separate the cognitive effects of HCV from comorbid substance abuse. The authors detail the specific areas of deficit that are present in those with HCV.
20. Forton D, Hamilton G, Allsop J, et al. Cerebral immune activation in chronic hepatitis C infection: A magnetic resonance spectroscopy study. J Hepatol 2008; 49:316-322.
21. Letendre S, Cherner M, Ellis R, et al. The effects of hepatitis C, HIV, and methamphetamine dependence on neuropsychological performance: biological correlates of disease. AIDS 2005; 19:S72-S78.
22. Martin E, Novak R, Fendrich M, et al. Stroop performance in drug users classified by HIV and hepatitis C virus serostatus. J Int Neuropsychol Soc 2004; 10:298-300. (Pubitemid 38418187)
23. Ryan E, Morgello S, Isaacs K, et al. Neuropsychiatric impact of hepatitis C on advanced HIV. Neurology 2004; 62:957-962. (Pubitemid 38435785)
24. Gongvatana A, Schweinsburg B, Taylor M, et al. White matter tract injury and cognitive impairment in human immunodeficiency virus-infected individuals. J Neurovirol 2009; 22:1-9. This article demonstrates how injury to certain brain areas can produce the cognitive impairment seen in individuals with HIV disease.
25. Cherner M, Letendre S, Heaton R, et al. Hepatitis C augments cognitive deficits associated with HIV infection and methamphetamine. Neurology 2005; 64:1343-1347. (Pubitemid 40570498)
26. Murray J, Fishman S, Ryan E, et al. Clinicopathologic correlates of hepatitis C virus in brain: a pilot study. J Neurovirol 2008; 14:17-27. This article presents pilot data on new evidence that cognitive dysfunction may be a result of the presence of the HCV virus in the brain. This is a new and emerging research track to examine the etiology of cognitive impairment.
27. Ryan L, Zheng J, Brester M, et al. Plasma levels of soluble CD14 and tumor necrosis factor-alpha type II receptor correlate with cognitive dysfunction during human immunodeficiency virus type 1 infection. J Infect Dis 2001; 184:699-706. (Pubitemid 32826420)
28. Greub G, Ledergerber B, Battegay M, et al. Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study. Lancet 2000; 356:1800-1805. (Pubitemid 30954033)
29. Telfer P, Brown D, Devereux H, et al. HCV RNA levels of HIV infection: evidence for a viral interaction in hemophilic patients. Br J Haematol 1994; 88:397-399. (Pubitemid 24318193)
30. Pol S, Fontaine H, Carnot F, et al. Predictive factors for development of cirrhosis in parenterally acquired chronic hepatitis C: a comparison between immunocompetent and immunocompromised patients. J Hepatol 1998; 29:12-19. (Pubitemid 28307978)
31. Graham C, Banden L, Yu E, et al. Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: A meta-analysis. Clin Infect Dis 2001; 33:562-569. (Pubitemid 32709592)
32. Graham C, Wells A, Edwards E, et al. Effect of exposure to injection drugs or alcohol on antigen-specific immune responses in HIV and hepatitis C virus coinfection. J Infect Dis 2007; 195:847-856. (Pubitemid 46363930)
33. Graham C, Koziel M. Why should hepatitis C affect immune reconstitution in HIV-1-infected patients? Lancet 2000; 356:1865-1866.
34. Girardi E, Sabin C, Monforte A. Late diagnosis of HIV infection: Epidemiological features, consequences and strategies to encourage earlier testing. J Acquir Immune Defic Syndr 2007; 46:S3-S8. (Pubitemid 47312320)
35. Rothman R, Ketlogetswe K, Dolan T, et al. Preventive care in the emergency department: should emergency departments conduct routine HIV screening? A systematic review. Acad Emerg Med 2003; 10:278-285. (Pubitemid 36292631)
36. Gandhi NR, Skanderson M, Gordon KS, et al. Delayed presentation for human immunodeficiency virus (HIV) care among veterans. Med Care 2007; 45:1105-1109.
37. Huckans MS, Blackwell AD, Harms TA, et al. Integrated hepatitis C virus treatment: addressing comorbid substance use disorders and HIV infection. AIDS 2005; 19 (Suppl 3):S106-S115. (Pubitemid 41682177)
38. Rifai M, Moles J, Lehman L, et al. Hepatitis C screening and treatment outcomes in patients with substance use/dependence disorders. Psychosomatics 2006; 47:112-122. (Pubitemid 43346958)
39. Alvarez DF, Latorre JS. Hepatitis C virus and HIV coinfection: clinical management and new strategies. AIDS Read 2004; 14 (10 Suppl):S16-S21.
40. Loftis J, Hauser P. The phenomenology and treatment of interferon-induced depression. J Aff Dis 2004; 82:175-190.
41. Ances BM, Clifford DB. HIV-associated neurocognitive disorders and the impact of combination antiretroviral therapies. Curr Neurol Neurosci Rep 2008; 6:455-461.
42. Kumar R, Singla V, Kacharya S. Impact and management of hepatitis B and hepatitis C virus co-infection in HIV patients. Trop Gastroenterol 2008; 29:136-147.
43. Sulkowski MS. Viral hepatitis and HIV coinfection. J Hepatol 2008; 48:353-367; Epub 2007 Dec 4.
44. Loftis JM, Hauser P. Treating hepatitis C in patients with comorbid psychiatric and substance use disorders. Directions Psychiatry 2008; 28:227-243. An important review of the treatment of HCV patients with IFN while managing depression and other side effects.
45. Beck A, Steer R, Brown G. Beck depression inventory manual. 2nd ed. New York: Psychological Corporation; 1996.
46. Willenbring M. Integrating care for patients with infectious, psychiatric, and substance use disorders: concepts and approaches. AIDS 2005; 19:S227-S237.